INIS
drugs
100%
decision making
74%
design
74%
pediatrics
74%
optimization
74%
extrapolation
74%
simulation
64%
data
50%
populations
44%
stochastic processes
42%
patients
38%
sampling
38%
sensitivity
37%
accumulation
37%
genetics
37%
antigens
37%
performance
31%
strains
31%
detection
31%
precision
30%
adults
29%
accuracy
29%
children
29%
clearance
24%
information
20%
errors
18%
interactions
17%
values
15%
balances
14%
molecules
14%
risks
14%
glycoproteins
12%
devices
12%
hiv
12%
computerized tomography
12%
activity levels
12%
range
11%
distribution
9%
doses
9%
roots
9%
volume
9%
mutations
6%
proteins
6%
monoclonal antibodies
5%
administration
5%
concentration
5%
Python
5%
demand
5%
size
5%
computer codes
5%
Keyphrases
Pediatric Extrapolation
74%
Stochastic Estimation
46%
Pediatric Pharmacotherapy
40%
Analytical Sensitivity
37%
SARS-CoV-2 Antigen
37%
Delta Variant
37%
Darunavir
37%
Pharmacokinetic Study
37%
Pharmacokinetics
37%
Low Viral Load
22%
Poor Performance
22%
Simulation-based Estimation
21%
Pediatric Drug Development
21%
Parameter Precision
18%
Simulation-based Approach
18%
Number of Patients
18%
Meropenem
18%
Omicron Strain
14%
Delta Strain
14%
Normalized Root Mean Square Error
12%
Relative Bias
12%
Mean Absolute Percentage Error
12%
3-design
12%
Q Estimation
12%
Clearance Volume
12%
Parameter-estimation Precision
12%
Parameter Estimation
9%
Model-based Approach
9%
Parenteral Administration
9%
Pediatric Research
9%
Drug Development
9%
Monoclonal Antibody
9%
Regulatory Agencies
9%
Oral Administration
9%
Small Populations
9%
Olanzapine
9%
Source Population
9%
Childrens
9%
Framework for Assessment
9%
Risk-benefit Ratio
9%
Acceptable Thresholds
9%
Python Software
9%
Mosunetuzumab
9%
Pediatric
9%
Stochastic Simulation
9%
Informed Decision-making
9%
Extrapolation Method
9%
Design Optimization
9%
Concentration Data
9%
Hercules
9%
